This existing drug can prevent COVID death
In a recent study published in The Lancet, researchers found an inexpensive repurposed drug called fluvoxamine can save the lives of COVID-19 patients and cut...
Nose could be the key to treating severe COVID-19
In a new study from Newcastle University, researchers have shed new light on early events in the battle between COVID-19 and the immune system...
These people more likely to get severe COVID-19 after vaccination
In a new study from Yale, researchers found although breakthrough SARS-CoV-2 infections tend to be mild, more older adults have developed severe breakthrough cases...
Heart problem caused by COVID-19 vaccines is rare and mild
In a new study from the University of Utah, researchers found most adolescents and young adults who developed a rare heart problem after being...
A third COVID vaccine is essential for these people
In a new study from the Deutsches Zentrum Immuntherapie, researchers examined patients who had no immune protection against the COVID-19 infection after two vaccinations...
What we know about the omicron variant
While the delta variant continues causing a surge of COVID-19 cases and hospitalizations in the United States, epidemiologists around the world are trying to...
Why a drug used to treat severe COVID-19 may only benefit men
In a new study from the University of Calgary, researchers found how dexamethasone, the main treatment for severe COVID-19 lung infections, alters how immune...
Should I mix and match my COVID-19 booster shot?
As concerns about the omicron variant mount, federal public health officials have strengthened their stance on booster shots for COVID-19 vaccines.
On Monday, U.S. Centers...
Understanding omicron, the new COVID-19 variant
Countries around the world are making preparations against omicron, a new variant of the novel coronavirus that causes COVID-19.
Although it hasn't yet been detected...
How COVID-19 harms the brain, according to new study
In a new study from Thomas Jefferson University, researchers found that approximately one in 100 patients hospitalized with COVID-19 will likely develop complications of...